GBS and CMV vaccines in pipeline development
GBS and CMV vaccines in pipeline development
Group B streptococcus (GBS) vaccines and cytomegalovirus (CMV) have been in the making for decades. Both represent important unmet medical needs in pediatrics. While these vaccines still remain far from licensure, there are significant new developments in both areas.
283-288
Jones, Christine E.
48229079-8b58-4dcb-8374-d9481fe7b426
Heath, Paul T.
751321bd-5245-4f79-b57a-6d3b6de61b32
Le Doare, Kirsty
9424dc5c-4484-41d3-86dd-29cfaffb43f5
20 August 2021
Jones, Christine E.
48229079-8b58-4dcb-8374-d9481fe7b426
Heath, Paul T.
751321bd-5245-4f79-b57a-6d3b6de61b32
Le Doare, Kirsty
9424dc5c-4484-41d3-86dd-29cfaffb43f5
Jones, Christine E., Heath, Paul T. and Le Doare, Kirsty
(2021)
GBS and CMV vaccines in pipeline development.
In,
Vesikari, Timo and Van Damme, Pierre
(eds.)
Pediatric Vaccines and Vaccinations: A European Textbook.
2 ed.
Springer Cham, .
(doi:10.1007/978-3-030-77173-7_24).
Record type:
Book Section
Abstract
Group B streptococcus (GBS) vaccines and cytomegalovirus (CMV) have been in the making for decades. Both represent important unmet medical needs in pediatrics. While these vaccines still remain far from licensure, there are significant new developments in both areas.
This record has no associated files available for download.
More information
e-pub ahead of print date: 19 August 2021
Published date: 20 August 2021
Identifiers
Local EPrints ID: 484483
URI: http://eprints.soton.ac.uk/id/eprint/484483
PURE UUID: 2facefd2-da9c-488b-b686-c8790e401212
Catalogue record
Date deposited: 16 Nov 2023 13:25
Last modified: 18 Mar 2024 03:39
Export record
Altmetrics
Contributors
Author:
Paul T. Heath
Author:
Kirsty Le Doare
Editor:
Timo Vesikari
Editor:
Pierre Van Damme
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
